4//SEC Filing
Eckelman Brendan P. 4
Accession 0001739614-23-000016
CIK 0001739614other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:17 PM ET
Size
11.5 KB
Accession
0001739614-23-000016
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Transactions
- Sale
Common Stock
2023-03-01$24.20/sh−39,600$958,348→ 2,035,953 total(indirect: By Trust) - Sale
Common Stock
2023-03-01$24.71/sh−400$9,883→ 2,035,553 total(indirect: By Trust)
Holdings
- 160,000(indirect: By Trust)
Common Stock
- 160,000(indirect: By Trust)
Common Stock
Eckelman Brendan P.
DirectorChief Scientific Officer10% Owner
Transactions
- Sale
Common Stock
2023-03-01$24.20/sh−39,600$958,348→ 2,035,953 total(indirect: By Trust) - Sale
Common Stock
2023-03-01$24.71/sh−400$9,883→ 2,035,553 total(indirect: By Trust)
Holdings
- 160,000(indirect: By Trust)
Common Stock
- 160,000(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Eckelman Living Trust dated February 5, 2014.
- [F2]The shares were sold in multiple transactions at prices ranging from $23.70 to $24.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]These securities are directly owned by the Eckelman Living Trust dated February 5, 2014. Brendan P. Eckelman is the trustee of the Eckelman Living Trust dated February 5, 2014 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Eckelman Living Trust dated February 5, 2014.
- [F4]The shares were sold in multiple transactions at prices ranging from $24.70 to $24.73, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F5]These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor son. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.
- [F6]These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor daughter. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001766433
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:17 PM ET
- Size
- 11.5 KB